Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Richard Lottenberg, MD
Researcher Professor Emeritus of Medicine
University of Florida College of Medicine
P.O. Box 100215
Gainesville, Florida, United States
Dr. Richard Lottenberg is a faculty member in the Department of Medicine at the University of Florida. He has previously served as Chief of the Division of Hematology/Oncology and Director of the Adult Sickle Cell Program. His research focus is in health services. He is currently a co-investigator of a multi- institutional NIH grant (Southeastern Exploratory Center of Excellence in Sickle Cell Disease).
Dr. Lottenberg leads the outreach core activity addressing the implementation and evaluation of primary care provider-based medical homes for the care of patients with sickle cell disease. His other research projects address the underuse of hydroxyurea therapy. He has been a member of the American Society of Hematology (ASH) committee on governmental Affairs since 2005 and leads the ASH Sickle Cell Disease Work group. He is on the NHLBI panel developing sickle cell disease clinical guidelines and serves as the team leader for the hydroxyurea therapy chapter.
+myBinderRelated Content
-
Donald Rucknagel, MD, PhDDr. Rucknagel pioneered the use of incen...
-
Susan Claster, MDDr. Claster graduated from the Universit...
-
Unanticipated consequences identified after implementation of a pediatric emergency department (PED)-based intranasa...Background: The 2014 National Heart Lun...
-
Associations between environmental factors and hospital admissions for sickle cell diseaseSickle cell disease is an increasing glo...
-
Cohen Children’s Medical Center Northwell HealthThe mission of the Sickle Cell Program a...
-
Sickle Cell Disease in the Emergency Department: Confronting Barriers to Care“You’re too pretty to have a disease...
-
Hospitals See No Link Between US Opioid Crisis and Patients’ Use of Treatment, Study ReportsThe U.S. opioid epidemic is not linked t...
